Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1871 1
1918 2
1919 1
1920 1
1924 1
1925 1
1928 1
1929 1
1933 1
1935 1
1936 1
1938 4
1939 2
1943 3
1944 5
1945 304
1946 987
1947 959
1948 1001
1949 640
1950 80
1951 660
1952 1557
1953 1947
1954 2138
1955 2446
1956 2289
1957 2533
1958 2297
1959 2133
1960 2360
1961 2583
1962 1778
1963 580
1964 1172
1965 5282
1966 8580
1967 9209
1968 10322
1969 11712
1970 12866
1971 13473
1972 14308
1973 15282
1974 15823
1975 16016
1976 17047
1977 16953
1978 18256
1979 19335
1980 19211
1981 20284
1982 22032
1983 24549
1984 26622
1985 26347
1986 26967
1987 27708
1988 28743
1989 31535
1990 33833
1991 34323
1992 34538
1993 36546
1994 38334
1995 39103
1996 39975
1997 40575
1998 41337
1999 43068
2000 45431
2001 49110
2002 53276
2003 56457
2004 58324
2005 63216
2006 69314
2007 74090
2008 79206
2009 83976
2010 91440
2011 98867
2012 102240
2013 106672
2014 108726
2015 110204
2016 109751
2017 113507
2018 117607
2019 119887
2020 129876
2021 133716
2022 131719
2023 119134
2024 127221
2025 101465
2026 79

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,019,435 results

Results by year

Filters applied: . Clear all
Page 1
AE 941.
[No authors listed] [No authors listed] Drugs R D. 2004;5(2):83-9. doi: 10.2165/00126839-200405020-00003. Drugs R D. 2004. PMID: 15293867 Review.
AE 941 [Arthrovas, Neoretna, Psovascar] is shark cartilage extract that inhibits angiogenesis. ...The agreement provides AEterna with upfront and milestone payments, as well as a return on manufacturing and sales of AE 941. AEterna Laboratories had granted Alcon Lab …
AE 941 [Arthrovas, Neoretna, Psovascar] is shark cartilage extract that inhibits angiogenesis. ...The agreement provides AEterna with …
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.
Hinkle JT, Graziosi M, Nayak SM, Yaden DB. Hinkle JT, et al. JAMA Psychiatry. 2024 Dec 1;81(12):1225-1235. doi: 10.1001/jamapsychiatry.2024.2546. JAMA Psychiatry. 2024. PMID: 39230883 Free PMC article.
STUDY SELECTION: Two independent reviewers screened articles of classic psychedelics (lysergic acid diethylamide [LSD], psilocybin, dimethyltryptamine [DMT], and 5-methoxy-N,N-dimethyltryptamine [5-MeO-DMT]) involving administration in clinical or research contexts. DATA EXTRACTI …
STUDY SELECTION: Two independent reviewers screened articles of classic psychedelics (lysergic acid diethylamide [LSD], psilocybin, dimethyl …
AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
Li Y, Li J, He J, Tao C. Li Y, et al. PLoS One. 2024 Mar 21;19(3):e0300919. doi: 10.1371/journal.pone.0300919. eCollection 2024. PLoS One. 2024. PMID: 38512919 Free PMC article.
Utilizing data from the Vaccine Adverse Event Reporting System (VAERS) from 1990 to 2016, this study particularly focuses on AEs to evaluate LLMs' capability for AE extraction. ...The encouraging performance of the AE-GPT underscores LLMs' potential in proces …
Utilizing data from the Vaccine Adverse Event Reporting System (VAERS) from 1990 to 2016, this study particularly focuses on AEs to e …
A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events.
Melnychuk L, Perlman-Arrow S, Lisboa Bastos M, Menzies D. Melnychuk L, et al. Clin Infect Dis. 2023 Jul 26;77(2):287-294. doi: 10.1093/cid/ciad246. Clin Infect Dis. 2023. PMID: 37125482
However, the occurrence of potentially serious adverse events (AE) is a limitation of TPT regimens. We conducted a systemic review and meta-analysis to estimate the incidence of AE and hepatotoxicity with various TPT regimens to help inform clinical decision …
However, the occurrence of potentially serious adverse events (AE) is a limitation of TPT regimens. We conducted a systemic re …
Drug-induced angioedema.
Lerch M. Lerch M. Chem Immunol Allergy. 2012;97:98-105. doi: 10.1159/000335621. Epub 2012 May 3. Chem Immunol Allergy. 2012. PMID: 22613856
Angioedema (AE) is the end result of deep dermal, subcutaneous and/or submucosal swelling, and represents a major criterion in the definition of anaphylaxis. ...A comprehensive investigation of AE must include analysis of complement factors, tryptase levels as well …
Angioedema (AE) is the end result of deep dermal, subcutaneous and/or submucosal swelling, and represents a major criterion in the de …
A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.
Tsuboi H, Yonemoto K, Katsuoka K. Tsuboi H, et al. J Dermatol. 2005 Nov;32(11):921-5. doi: 10.1111/j.1346-8138.2005.tb00873.x. J Dermatol. 2005. PMID: 16361756 Review.
Chemotherapy-induced acral erythema (AE) is primarily induced by hydroxyurea, methotrexate, and cytarabine, although there are rare reports of AE induced by combination chemotherapy containing bleomycin. ...We also provide a summary of past cases of AE with E …
Chemotherapy-induced acral erythema (AE) is primarily induced by hydroxyurea, methotrexate, and cytarabine, although there are rare r …
Sirolimus-induced angioedema.
Wadei H, Gruber SA, El-Amm JM, Garnick J, West MS, Granger DK, Sillix DH, Migdal SD, Haririan A. Wadei H, et al. Am J Transplant. 2004 Jun;4(6):1002-5. doi: 10.1111/j.1600-6143.2004.00429.x. Am J Transplant. 2004. PMID: 15147436 Free article.
Sirolimus (SRL) is a macrolide immunosuppressant that has gained widespread use in organ transplantation. Its full spectrum of side-effects is yet to be defined. We describe herein three cases of SRL-induced angioedema (AE) in African-American (AA) primary renal all …
Sirolimus (SRL) is a macrolide immunosuppressant that has gained widespread use in organ transplantation. Its full spectrum of side-effec …
AE-941 (Neovastat): a novel multifunctional antiangiogenic compound.
Gingras D, Batist G, Béliveau R. Gingras D, et al. Expert Rev Anticancer Ther. 2001 Oct;1(3):341-7. doi: 10.1586/14737140.1.3.341. Expert Rev Anticancer Ther. 2001. PMID: 12113101
AE-941 (Neovastat) is a naturally occurring product extracted from cartilage and has antiangiogenic properties. ...Results from Phase I/II clinical trials indicate that AE-941, given orally, is well tolerated. Moreover, the median survival time in patients with rena …
AE-941 (Neovastat) is a naturally occurring product extracted from cartilage and has antiangiogenic properties. ...Results from Phase …
Real-world assessment of sparsentan's drug safety framework.
Fu W, Wang J, Xue Y, Pan D. Fu W, et al. Ren Fail. 2025 Dec;47(1):2461668. doi: 10.1080/0886022X.2025.2461668. Epub 2025 Feb 19. Ren Fail. 2025. PMID: 39972562 Free PMC article.
BACKGROUND: Sparsentan has been approved for reducing proteinuria in adult patients with primary IgA nephropathy (IgAN) at risk of rapid disease progression, yet comprehensive studies evaluating its drug safety framework are lacking. METHODS: Adverse event (AE) repo …
BACKGROUND: Sparsentan has been approved for reducing proteinuria in adult patients with primary IgA nephropathy (IgAN) at risk of rapid dis …
Chirurgie aortique totalement laparoscopique ou par laparotomie: comparaison des résultats après appariement par un score de propension.
Ricco JB, Cau J, Schneider F, Desvergnes M, Lefort N, Belmonte R. Ricco JB, et al. Bull Acad Natl Med. 2016 Mar;200(3):527-40; discussion 540-3. Bull Acad Natl Med. 2016. PMID: 28644602 Clinical Trial. French.
The incidence rate of AE during follow-up was calculated using the Kaplan-Meier method and the roles of the different covariables were analyzed using the Cox model. ...Occurrence of AE during follow-up was analyzed using the Cox model. Only two variables, laparoscop …
The incidence rate of AE during follow-up was calculated using the Kaplan-Meier method and the roles of the different covariables wer …
3,019,435 results
You have reached the last available page of results. Please see the User Guide for more information.